CytomX Therapeutics (CTMX) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 92 people. CytomX Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 971.6 M. CytomX Therapeutics conducts business under Healthcare
sector and is part of Pharmaceutical Products
industry. This company has 38.96 M outstanding shares of which 1.75 M shares are currently shorted by private and institutional investors with about 5.23 trading days to cover.
CytomX Therapeutics currently holds about 361.48 M in cash with 174.85 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.28.
Check CytomX Therapeutics Probability Of Bankruptcy